NEWROTEX LIMITED

Company number 11798939 · Monitor this company

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£469,720

Balance sheet as at 2023-07-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2019-01-31
Registered office: Wood Centre For Innovation Stansfield Park, Quarry Road, Headington, Oxford, Oxfordshire, England, OX3 8SB
Postcode: OX3 8SB
Capital: 1 GBP
Accounts category: Micro

Accounts

Last made up to: 2025-07-31
Next due by: 2027-04-30
Financial year end: 31 July

Confirmation statement

Last statement dated: 2026-04-21
Next due by: 2027-05-05

View filing history →

Nature of business (SIC)

72110 Research and experimental development on biotechnology

Officers 5 current

Lucy Ann WOODS Director

Appointed 2022-03-01

James Hugh Charteris MALLINSON Director

Appointed 2022-03-01

Christopher Ian Montague JONES Director

Appointed 2022-03-01

DR Alexander Kristian, Dr WOODS Director

Appointed 2019-01-31

DR Friedrich Wilhelm Ludwig Paul, Dr VOLLRATH Director

Appointed 2019-01-31

View all officers and resignations →

Contact details

Website: newrotex.com

Previous registered addresses 1

Address	Changed on
STERLING HOUSE 19/23 HIGH STREET, KIDLINGTON, OXFORDSHIRE, OX5 2DH, UNITED KINGDOM	2020-01-14

Competitors Oxford

1. BRACCO HORIZONS LIMITED

£526,148,027
2. GREY WOLF THERAPEUTICS LIMITED

£86,763,972
3. BLUE EARTH THERAPEUTICS LIMITED

£55,488,752
4. MOA TECHNOLOGY LIMITED

£48,156,558
5. PATHIOS THERAPEUTICS LIMITED

£45,729,623

This company ranks 47 among research and experimental development on biotechnology in Oxford.

Full league table →

The class of 2019

39%

of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.

A fact about the year, not a forecast for this company.